Saksham Pharmaceuticals (India) Limited - Company Profile

It is a pharma public limited company based in Burari, Delhi, India, established in 2011.
2011 Burari, Delhi, India Active
Last Updated:
Access Report
About Saksham Pharmaceuticals (India) Limited

Saksham Pharmaceuticals (India) Limited, a active public limited company, was established on 01 March 2011 in Burari, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232DL2011PLC215019. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 6 professional, Its leadership includes Neelam Jain (Director), Ankur Jain (Director), Saksham Jain (Additional Director). Past directors included Pawan Kumar, Durgesh Verma, Surinder Oberoi. It holds ₹1.23 Cr open charges and ₹3.10 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at First Floor, Out Of Khasra No. 19/26 At Main 100 Foota Road, Kaushik Enclave, Burari, Delhi, 110084.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2011PLC215019

  • Registration Number

    215019

  • Incorporation Date

    01 March 2011

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.23 Cr
  • Satisfied Charges ₹ 3.10 M
  • Revenue Growth **** 1.57%
  • Profit Growth **** 106.36%
  • Ebitda **** -222.73%
  • Net Worth 2.92%
  • Total Assets **** 19.88%
Company report

Saksham Pharmaceuticals (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Saksham Pharmaceuticals (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Saksham Pharmaceuticals (India) Limited?
Current Directors
Name Designation Appointment Date Status
Neelam Jain Director 01 Mar 2011 Current
Ankur Jain Director 01 Mar 2011 Current
Saksham Jain Additional Director 07 Dec 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Dec 2011 Past
Pramod Abcsdd Director 17 Jul 2012 Past
Pramod Abcsdd Director 18 Dec 2012 Past
Pramod Abcsdd Director 09 Aug 2014 Past
Pramod Abcsdd Director 17 Dec 2021 Past
Pramod Abcsdd Director 04 Aug 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Saksham Pharmaceuticals (India).

Saksham Pharmaceuticals (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.57% increase. The company also saw a substantial improvement in profitability, with a 106.36% increase in profit. The company's net worth moved up by a moderate rise of 2.92%.

Saksham Pharmaceuticals (India) revenue growth over time
Saksham Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 1.57%
*******
*******
*******
*******
Revenue from Operations
*******
 2.19%
*******
*******
*******
*******
Total Assets
*******
 19.88%
*******
*******
*******
*******
Profit or Loss
*******
 106.36%
*******
*******
*******
*******
Net Worth
*******
 2.92%
*******
*******
*******
*******
EBITDA
*******
 -222.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Saksham Pharmaceuticals (India)?

In 2023, Saksham Pharmaceuticals (India) had a promoter holding of 60.85% and a public holding of 39.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,261,550.00

Satisfied Charges

₹3,100,000.00

Charges Breakdown by Lending Institutions
  • Others : 1.23 Cr
Latest Charge Details
Date Lender Amount Status
25 Jun 2019 Others ₹1.23 Cr Open
23 Sep 2014 Hdfc Bank Limited ₹3.10 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Saksham Pharmaceuticals (India)?

Saksham Pharmaceuticals (India) has a workforce of 6 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Saksham Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saksham Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Saksham Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Saksham Pharmaceuticals (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Saksham Pharmaceuticals (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Saksham Jain was appointed as a Additional Director was appointed as a Additional Director on 07 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Charges

    A charge registered on 23 Sep 2014 via Charge ID 10522329 with Hdfc Bank Limited was fully satisfied on 29 Mar 2023. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 1.23 Cr registered on 25 Jun 2019 with Charge ID 100273651 was modified on 23 Sep 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.23 Cr with Charge ID 100273651 was registered on 25 Jun 2019. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Saksham Pharmaceuticals (India) Limited?

The CIN of Saksham Pharmaceuticals (India) Limited is U24232DL2011PLC215019.

Where is Saksham Pharmaceuticals (India) Limited headquartered?

Saksham Pharmaceuticals (India) Limited is headquartered at First Floor, Out Of Khasra No. 19/26 At Main 100 Foota Road, Kaushik Enclave, Burari, Delhi, 110084.

When was Saksham Pharmaceuticals (India) Limited incorporated?

Saksham Pharmaceuticals (India) Limited was incorporated on 01 March 2011.

Who are the current directors of Saksham Pharmaceuticals (India) Limited?

The current directors of Saksham Pharmaceuticals (India) Limited are

What is the primary industry of Saksham Pharmaceuticals (India) Limited?

The primary industry of Saksham Pharmaceuticals (India) Limited is Trade.

Is Saksham Pharmaceuticals (India) Limited a listed company?

Saksham Pharmaceuticals (India) Limited is unlisted.

What is the capital structure of Saksham Pharmaceuticals (India) Limited?

The authorized capital of Saksham Pharmaceuticals (India) Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Saksham Pharmaceuticals (India) Limited?

The compliance status of Saksham Pharmaceuticals (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available